Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Crinetics Pharmaceuticals Inc
About CRNX
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead development candidate, PALSONIFY (paltusotine), is the first investigational once-daily, oral, selective somatostatin receptor type 2 (SST2) nonpeptide agonist that is in clinical development for acromegaly and carcinoid syndrome associated with neuroendocrine tumors. Its second product candidate is Atumelnant, which is in clinical development for congenital adrenal hyperplasia (CAH) and patients with either Cushing's disease or Ectopic ACTH Syndrome (EAS). Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Find out what a historical investment in Crinetics Pharmaceuticals Inc would be worth today using our CRNX stock calculator.
Market Capitalisation
$3.68B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
666.54K
High today
$36.55
Low today
$35.23
Open price
$35.24
52-week high
$57.99
52-week low
$25.83
Ready to start your investing journey with Stake?
Open an accountHow do I buy CRNX shares in Australia?
Buying CRNX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Crinetics Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CRNX
What is the ticker symbol of Crinetics Pharmaceuticals Inc?
The ticker symbol for Crinetics Pharmaceuticals Inc is CRNX.
How much is one share of CRNX?
One share of CRNX is valued at $36.34 as of 20 May 2026.
What is the market capitalisation of Crinetics Pharmaceuticals Inc CRNX?
As of 20 May 2026 Crinetics Pharmaceuticals Inc has a market cap of $3.68B.
What is the 52-week high for Crinetics Pharmaceuticals Inc stock?
The Crinetics Pharmaceuticals Inc 52-week high stock price is $57.99.
What is the 52-week low for Crinetics Pharmaceuticals Inc stock?
The Crinetics Pharmaceuticals Inc 52-week low stock price is $25.83.
Can I buy CRNX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CRNX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRNX on Stake
- Buy CRNX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CRNX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CRNX related stocks